Hoff Ana O (33 results)

Condition: As New. Unread book in perfect condition.

Condition: New. In.

Condition: New.

Condition: New.

Condition: As New. Unread book in perfect condition.

Condition: New. This book offers insight into an intriguing group of rare cancers, examining a surge of recent advances in genetics and molecular biology, and offering instruction in new modalities of treatment. Coverage includes chemotherapy, surgical management, and more. Editor(s): Yao, James C.; Hoff, Paulo M.; Hoff, Ana O. Series: Current Clinical Oncology. Num Pages: 280 pages, 27 black & white tables, biography. BIC Classification: MJCL; MJG; MNK. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 18. Weight in Grams: 433. . 2013. Paperback. . . . .

Condition: New. pp. 280.

Paperback. Condition: Brand New. 2012 edition. 360 pages. 9.21x5.98x0.63 inches. In Stock.

Taschenbuch. Condition: Neu. Neuroendocrine Tumors | James C. Yao (u. a.) | Taschenbuch | Current Clinical Oncology | xii | Englisch | 2013 | Humana | EAN 9781617797569 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Condition: New. This book offers insight into an intriguing group of rare cancers, examining a surge of recent advances in genetics and molecular biology, and offering instruction in new modalities of treatment. Coverage includes chemotherapy, surgical management, and more. Editor(s): Yao, James C.; Hoff, Paulo M.; Hoff, Ana O. Series: Current Clinical Oncology. Num Pages: 280 pages, 27 black & white tables, biography. BIC Classification: MJCL; MJG; MNK. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 18. Weight in Grams: 433. . 2013. Paperback. . . . . Books ship from the US and Ireland.

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: New. This book offers insight into an intriguing group of rare cancers, examining a surge of recent advances in genetics and molecular biology, and offering instruction in new modalities of treatment. Coverage includes chemotherapy, surgical management, and more. Editor(s): Yao, James C.; Hoff, Paulo M.; Hoff, Ana O. Series: Current Clinical Oncology. Num Pages: 280 pages, 27 black & white tables, biography. BIC Classification: MJCL; MJG; MJH; MNK. Category: (P) Professional & Vocational. Dimension: 245 x 172 x 20. Weight in Grams: 562. . 2010. 2012. Hardback. . . . .

Condition: Sehr gut. Zustand: Sehr gut | Seiten: 280 | Sprache: Englisch | Produktart: Bücher | New research has shown that neuroendocrine tumors are more common than previously thought.  Progress in our understanding of the molecular pathogenesis of these not-so-rare cancers has resulted in renewed interest in developing innovative therapeutic options.  In particular, novel molecular targeted agents have been shown to have significant anti-tumor activity, and integration of these therapies has led to critical advances in management.  In this volume, an outstanding group of the world¿s leaders in the field have assembled to convey their knowledge of the epidemiology, biology, and management of all the major types of neuroendocrine tumors.  The book takes a multi-modality approach to understanding disease processes and therapeutics, including chapters on medical and surgical treatment as well as a chapter devoted to imaging.  Throughout, the authors emphasize recent advances in our understanding of molecular biology and the subsequent emerging therapeutic options.

Condition: New. pp. 280.

Condition: New. In.

Hardcover. Condition: Brand New. 1st edition. 267 pages. 9.75x6.50x0.50 inches. In Stock.

Condition: New. This book offers insight into an intriguing group of rare cancers, examining a surge of recent advances in genetics and molecular biology, and offering instruction in new modalities of treatment. Coverage includes chemotherapy, surgical management, and more. Editor(s): Yao, James C.; Hoff, Paulo M.; Hoff, Ana O. Series: Current Clinical Oncology. Num Pages: 280 pages, 27 black & white tables, biography. BIC Classification: MJCL; MJG; MJH; MNK. Category: (P) Professional & Vocational. Dimension: 245 x 172 x 20. Weight in Grams: 562. . 2010. 2012. Hardback. . . . . Books ship from the US and Ireland.

Condition: new. Questo è un articolo print on demand.

Condition: new. Questo è un articolo print on demand.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -New research has shown that neuroendocrine tumors are more common than previously thought. Progress in our understanding of the molecular pathogenesis of these not-so-rare cancers has resulted in renewed interest in developing innovative therapeutic options. In particular, novel molecular targeted agents have been shown to have significant anti-tumor activity, and integration of these therapies has led to critical advances in management. In this volume, an outstanding group of the world's leaders in the field have assembled to convey their knowledge of the epidemiology, biology, and management of all the major types of neuroendocrine tumors. The book takes a multi-modality approach to understanding disease processes and therapeutics, including chapters on medical and surgical treatment as well as a chapter devoted to imaging. Throughout, the authors emphasize recent advances in our understanding of molecular biology and the subsequent emerging therapeutic options. 280 pp. Englisch.

Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Emphasizes emerging therapeutic optionsDiscusses the practical applications of novel molecular targeted agentsConveys recent advances in the understanding of molecular pathogenesisCovers all major types of neuroendocrine tumors.

Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -New research has shown that neuroendocrine tumors are more common than previously thought. Progress in our understanding of the molecular pathogenesis of these not-so-rare cancers has resulted in renewed interest in developinginnovative therapeutic options. In particular, novel molecular targeted agents have been shown to have significant anti-tumor activity, and integration of these therapies has led to critical advances in management.In this volume, an outstanding group of the world¿s leaders in the field have assembled to convey their knowledge of the epidemiology, biology, and management of allthemajor types of neuroendocrine tumors. The book takes a multi-modality approach to understanding disease processes and therapeutics, including chapters on medical and surgical treatment as well as a chapter devoted to imaging. Throughout, the authors emphasize recent advances in our understanding of molecular biology and the subsequent emerging therapeutic options.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 280 pp. Englisch.

Condition: New. Print on Demand pp. 280.

Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Emphasizes emerging therapeutic optionsDiscusses the practical applications of novel molecular targeted agentsConveys recent advances in the understanding of molecular pathogenesisCovers all major types of neuroendocrine tumors.

Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - New research has shown that neuroendocrine tumors are more common than previously thought. Progress in our understanding of the molecular pathogenesis of these not-so-rare cancers has resulted in renewed interest in developing innovative therapeutic options. In particular, novel molecular targeted agents have been shown to have significant anti-tumor activity, and integration of these therapies has led to critical advances in management. In this volume, an outstanding group of the world's leaders in the field have assembled to convey their knowledge of the epidemiology, biology, and management of all the major types of neuroendocrine tumors. The book takes a multi-modality approach to understanding disease processes and therapeutics, including chapters on medical and surgical treatment as well as a chapter devoted to imaging. Throughout, the authors emphasize recent advances in our understanding of molecular biology and the subsequent emerging therapeutic options.

Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -New research has shown that neuroendocrine tumors are more common than previously thought. Progress in our understanding of the molecular pathogenesis of these not-so-rare cancers has resulted in renewed interest in developing innovative therapeutic options. In particular, novel molecular targeted agents have been shown to have significant anti-tumor activity, and integration of these therapies has led to critical advances in management. In this volume, an outstanding group of the world's leaders in the field have assembled to convey their knowledge of the epidemiology, biology, and management of all the major types of neuroendocrine tumors. The book takes a multi-modality approach to understanding disease processes and therapeutics, including chapters on medical and surgical treatment as well as a chapter devoted to imaging. Throughout, the authors emphasize recent advances in our understanding of molecular biology and the subsequent emerging therapeutic options. 280 pp. Englisch.

Condition: New. PRINT ON DEMAND pp. 280.

Buch. Condition: Neu. Neuroendocrine Tumors | James C. Yao (u. a.) | Buch | Current Clinical Oncology | xii | Englisch | 2011 | Humana | EAN 9781603279963 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.

Buch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -New research has shown that neuroendocrine tumors are more common than previously thought. Progress in our understanding of the molecular pathogenesis of these not-so-rare cancers has resulted in renewed interest in developinginnovative therapeutic options. In particular, novel molecular targeted agents have been shown to have significant anti-tumor activity, and integration of these therapies has led to critical advances in management.In this volume, an outstanding group of the world¿s leaders in the field have assembled to convey their knowledge of the epidemiology, biology, and management of allthemajor types of neuroendocrine tumors. The book takes a multi-modality approach to understanding disease processes and therapeutics, including chapters on medical and surgical treatment as well as a chapter devoted to imaging. Throughout, the authors emphasize recent advances in our understanding of molecular biology and the subsequent emerging therapeutic options.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 280 pp. Englisch.